No.

Publication Date

Citing Article

1

2023

Li-Li Ren, Xiao-Jun Li, Ting-Ting Duan, Zheng-Hai Li, Jun-Zheng Yang, Ya-Mei Zhang, Liang Zou, Hua Miao, Ying-Yong Zhao. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities, Chemico-Biological Interactions. 2023; 369: 110289110289.  https://doi.org/10.1016/j.cbi.2022.110289

2

2022

Emily Truong, Mazen Noureddin. The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease, Clinics in Liver Disease. 2022; 26: 213.  https://doi.org/10.1016/j.cld.2022.01.008

3

2023

Alessandro Mantovani, Chiara Zusi, Alessandro Csermely, Antonio Taverna, Davide Cappelli, Micol Pagani, Luca Valenti, Claudio Maffeis, Giovanni Targher. Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis, Nutrition, Metabolism and Cardiovascular Diseases. 2023; 33: 1093.  https://doi.org/10.1016/j.numecd.2023.03.004

4

2023

Xilin Zhao, Xuelan He, Wentao Wei, Kaipeng Huang. USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1, European Journal of Pharmacology. 2023; 947: 175671175671.  https://doi.org/10.1016/j.ejphar.2023.175671

5

2022

Hua Miao, Yamei Zhang, Xiaoyong Yu, Liang Zou, Yingyong Zhao. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy, Frontiers in Pharmacology. 2022; 13: 969930.  https://doi.org/10.3389/fphar.2022.969930

6

2022

Xiao-Yong Yu, Qian Sun, Ya-Mei Zhang, Liang Zou, Ying-Yong Zhao. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis, Frontiers in Pharmacology. 2022; 13: 860588.  https://doi.org/10.3389/fphar.2022.860588

7

2021

P. Kravchun, O. Kadykova, U. Herasymchuk. ADIPONUTRIN LEVELS IN HYPERTENSIVE PATIENTS DEPENDING ON THE DEGREE OF OBESITY, Inter Collegas. 2021; 8: 10.  https://doi.org/10.35339/ic.8.1.10-17

8

2022

Pin Gong, Peipei Wang, Sihui Pi, Yuxi Guo, Shuya Pei, Wenjuan Yang, Xiangna Chang, Lan Wang, Fuxin Chen. Proanthocyanidins Protect Against Cadmium-Induced Diabetic Nephropathy Through p38 MAPK and Keap1/Nrf2 Signaling Pathways, Frontiers in Pharmacology. 2022; 12: 801048.  https://doi.org/10.3389/fphar.2021.801048

9

2021

P. G. Kravchun, O. I. Kadykova, U. S. Herasymchuk. Adiponutrin as a Marker of Metabolic Disorders in Patients with Hypertension with Overweight and Obesity, Ukraïnsʹkij žurnal medicini, bìologìï ta sportu. 2021; 6: 77.  https://doi.org/10.26693/jmbs06.02.077

10

2025

Xiaoling Cheng, Wenli Hao, Silin Yu, Xvjie Gao, Liyuan Qu, Chang Liu, Yanli Wang, Yifan Sun, Jian Huang, Lu Yang, Jinhui Wang. Nephroprotective effects of Amomum kravanh essential oil by inhibition of ferroptosis regulated by Nrf2/HO-1 signaling pathway, Phytomedicine. 2025; 142: 156762156762.  https://doi.org/10.1016/j.phymed.2025.156762

11

2022

Yue-Qi Tan, Yan-Ni Wang, Hao-Yu Feng, Zhi-Yuan Guo, Xia Li, Xiao-Li Nie, Ying-Yong Zhao. Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling, Free Radical Biology and Medicine. 2022; 184: 30.  https://doi.org/10.1016/j.freeradbiomed.2022.03.025

12

2024

Yingdan Zhao, Hanqing Wang, Yunhai Tang, Juan Wang, Xia Wu, Zifan He, Yayun He, Zhihuan Tang. SNHG16/miR‐205/HDAC5 is involved in the progression of renal fibrosis, Journal of Biochemical and Molecular Toxicology. 2024; 38: e23617.  https://doi.org/10.1002/jbt.23617

13

2024

Na Ren, Wen-Feng Wang, Liang Zou, Yan-Long Zhao, Hua Miao, Ying-Yong Zhao. The nuclear factor kappa B signaling pathway is a master regulator of renal fibrosis, Frontiers in Pharmacology. 2024; 14: 1335094.  https://doi.org/10.3389/fphar.2023.1335094

14

2024

Ziwei Chen, Shaobo Wu, Li Huang, Jing Li, Xueying Li, Yu Zeng, Zejun Chen, Ming Chen. Colonic microflora and plasma metabolite-based comparative analysis of unilateral ureteral obstruction-induced chronic kidney disease after treatment with the Chinese medicine FuZhengHuaYuJiangZhuTongLuo and AST-120, Heliyon. 2024; 10: e24987e24987.  https://doi.org/10.1016/j.heliyon.2024.e24987

15

2023

Jiali Fang, Yuhe Guo, Wei Yin, Lei Zhang, Guanghui Li, Junjie Ma, Lu Xu, Yunyi Xiong, Luhao Liu, Weiting Zhang, Zheng Chen. Neoxanthin alleviates the chronic renal failure-induced aging and fibrosis by regulating inflammatory process, International Immunopharmacology. 2023; 114: 109429109429.  https://doi.org/10.1016/j.intimp.2022.109429

16

2023

Xiaoqiang Wu, Xiangyong Tian, Guanghui Cao, Zhiwei Wang, Xuan Wu, Yue Gu, Tianzhong Yan. Distinct profiles of bile acid metabolism caused by gut microbiota in kidney transplantation recipients revealed by 16S rRNA gene sequencing, Archives of Physiology and Biochemistry. 2023; 1.  https://doi.org/10.1080/13813455.2023.2212331

17

2022

Alessandro Mantovani, Andrea Dalbeni, Giorgia Beatrice, Davide Cappelli, Fernando Gomez-Peralta. Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes, Journal of Clinical Medicine. 2022; 11: 968.  https://doi.org/10.3390/jcm11040968

18

2023

Yiyou LIN, Jiale WEI, Yehui ZHANG, Junhao HUANG, Sichen WANG, Qihan LUO, Hongxia YU, Liting JI, Xiaojie ZHOU, Changyu LI. Shen Qi Wan attenuates renal interstitial fibrosis through upregulating AQP1, Chinese Journal of Natural Medicines. 2023; 21: 359.  https://doi.org/10.1016/S1875-5364(23)60453-4

19

2022

Gang Cao, Hua Miao, Yan-ni Wang, Dan-qian Chen, Xia-qing Wu, Lin Chen, Yan Guo, Liang Zou, Nosratola D. Vaziri, Ping Li, Ying-yong Zhao. Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice, Acta Pharmacologica Sinica. 2022; 43: 2929.  https://doi.org/10.1038/s41401-022-00914-6

20

2023

Yan-ni Wang, Zhi-hao Zhang, Hong-jiao Liu, Zhi-yuan Guo, Liang Zou, Ya-mei Zhang, Ying-yong Zhao. Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease, Acta Pharmacologica Sinica. 2023; 44: 393.  https://doi.org/10.1038/s41401-022-00947-x

21

2022

Ying-Yong Zhao, Recent advances of gut microbiota in chronic kidney disease patients, Exploration of Medicine. 2022; 260.  https://doi.org/10.37349/emed.2022.00090

22

2022

Zengying Liu, Chen Guan, Chenyu Li, Ningxin Zhang, Chengyu Yang, Lingyu Xu, Bin Zhou, Long Zhao, Hong Luan, Xiaofei Man, Yan Xu. Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice, Frontiers in Pharmacology. 2022; 13: 862584.  https://doi.org/10.3389/fphar.2022.862584

23

2021

Liang-Pu Luo, Ping Suo, Li-Li Ren, Hong-Jiao Liu, Yamei Zhang, Ying-Yong Zhao. Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways, Frontiers in Pharmacology. 2021; 12: 800522.  https://doi.org/10.3389/fphar.2021.800522

24

2022

Yan-Ni Wang, Hong-Jiao Liu, Li-Li Ren, Ping Suo, Liang Zou, Ya-Mei Zhang, Xiao-Yong Yu, Ying-Yong Zhao. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway, Frontiers in Pharmacology. 2022; 13: 964370.  https://doi.org/10.3389/fphar.2022.964370

25

2022

Chang-E Yang, Yan-Ni Wang, Meng-Ru Hua, Hua Miao, Ying-Yong Zhao, Gang Cao. Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis, Ageing Research Reviews. 2022; 79: 101662101662.  https://doi.org/10.1016/j.arr.2022.101662

26

2023

Lidan Hu, Li Lin, Guoping Huang, Yi Xie, Zhaoyang Peng, Fei Liu, Guannan Bai, Wei Li, Langping Gao, Yan Wang, Qiuyu Li, Haidong Fu, Jingjing Wang, Qingnan Sun, Jianhua Mao. Metabolomic profiles in serum and urine uncover novel biomarkers in children with nephrotic syndrome, European Journal of Clinical Investigation. 2023; 53: e13978.  https://doi.org/10.1111/eci.13978

27

2022

Ziqiang Zhang, Yingying Sun, Hui Xie, Jiajia Wang, Xin Zhang, Zhangyu Shi, Yumei Liu. Protective effect of selenomethionine on kidney injury induced by ochratoxin A in rabbits, Environmental Science and Pollution Research. 2022; 30: 29874.  https://doi.org/10.1007/s11356-022-24297-7

28

2020

Zhendong Feng, Wenbin Liu, Han Xue Jiang, Haoran Dai, Chang Gao, Zhaocheng Dong, Yu Gao, Fei Liu, Zihan Zhang, Qihan Zhao, Lei Zhang, Baoli Liu. How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?, Frontiers in Pharmacology. 2020; 11: 994.  https://doi.org/10.3389/fphar.2020.00994

29

2023

Ademola Adetokunbo Oyagbemi, Temitayo Olabisi Ajibade, Oluwaseun Olanrewaju Esan, Moses Olusola Adetona, Ayobami Deborah Obisesan, Adewumi Victoria Adeogun, Omolola Victoria Awoyomi, Joseph Ayotunde Badejo, Aduragbenro Deborah A. Adedapo, Temidayo Olutayo Omobowale, Olayinka Israel Olaleye, Olufunke Eunice Ola-Davies, Adebowale Benard Saba, Adeolu Alex Adedapo, Sanah Malomile Nkadimeng, Lyndy Joy McGaw, Prudence Ngalula Kayoka-Kabongo, Momoh Audu Yakubu, Evaristus Nwulia, Oluwafemi Omoniyi Oguntibeju. Naringin abrogates angiotensin-converting enzyme (ACE) activity and podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension, Biomarkers. 2023; 28: 206.  https://doi.org/10.1080/1354750X.2022.2157489

30

2023

Lin-Lin Feng, Zheng Huang, Yun-Yuan Nong, Bing-Jian Guo, Qian-Yi Wang, Jing-Hua Qin, Ying He, Dan Zhu, Hong-Wei Guo, Yue-Lian Qin, Xin-Yu Zhong, Yue Guo, Bang Cheng, Song-Feng Ou, Zhi-Heng Su. Evaluation of aristolochic acid Ι nephrotoxicity in mice via 1H NMR quantitative metabolomics and network pharmacology approaches, Toxicology Research. 2023; 12: 282.  https://doi.org/10.1093/toxres/tfad020

31

2024

Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, Giovanni Targher. Steatotic liver disease, MASLD and risk of chronic kidney disease, Diabetes & Metabolism. 2024; 50: 101506101506.  https://doi.org/10.1016/j.diabet.2023.101506

32

2025

Alessandro Mantovani, Giovanni Targher. PNPLA3 variation and kidney disease, Liver International. 2025; 45: e16010.  https://doi.org/10.1111/liv.16010

33

2023

Meng-jie Huang, Yu-wei Ji, Jian-wen Chen, Duo Li, Tian Zhou, Peng Qi, Xu Wang, Xiao-fan Li, Yi-fan Zhang, Xiang Yu, Ling-ling Wu, Xue-feng Sun, Guang-yan Cai, Xiang-mei Chen, Quan Hong, Zhe Feng. Targeted VEGFA therapy in regulating early acute kidney injury and late fibrosis, Acta Pharmacologica Sinica. 2023; 44: 1815.  https://doi.org/10.1038/s41401-023-01070-1

34

2022

Hua Miao, Xia‐Qing Wu, Yan‐Ni Wang, Dan‐Qian Chen, Lin Chen, Nosratola D. Vaziri, Shougang Zhuang, Yan Guo, Wei Su, Shi‐Xing Ma, Huan‐Qiao Zhang, You‐Quan Shang, Xiao‐Yong Yu, Yan‐Long Zhao, Jia‐Rong Mao, Ming Gao, Jin‐Hua Zhang, Jin Zhao, Yuan Zhang, Li Zhang, Ying‐Yong Zhao, Gang Cao. 1‐Hydroxypyrene mediates renal fibrosis through aryl hydrocarbon receptor signalling pathway, British Journal of Pharmacology. 2022; 179: 103.  https://doi.org/10.1111/bph.15705